Showing results (451-460 of 467) with videos related to

Sort By:
Pageof 47
Elife|November 2, 2019
Retro-2 protects cells from ricin toxicity by inhibiting ASNA1-mediated ER targeting and insertion of tail-anchored proteinsDavid W Morgens, Charlene Chan, Andrew J Kane, et al.
Nature Communications|September 8, 2019
Mitigation of off-target toxicity in CRISPR-Cas9 screens for essential non-coding elementsJosh Tycko, Michael Wainberg, Georgi K Marinov, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 19, 2023
PET/CT Biomarkers Enable Risk Stratification of Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma Enrolled in the LOTIS-2 Clinical TrialJuan Pablo Alderuccio, Isildinha M Reis, Mehdi Hamadani, et al.
Blood Advances|February 22, 2023
A multicenter analysis of the outcomes with venetoclax in patients with relapsed mantle cell lymphomaYazeed Sawalha, Subir Goyal, Jeffrey M Switchenko, et al.
Blood|December 29, 2025
Brentuximab Vedotin and Nivolumab in Combination With Chemotherapy for Nonbulky, Early-Stage Classical Hodgkin LymphomaJeremy S Abramson, David J Straus, Nancy L Bartlett, et al.
Nature Biotechnology|November 2, 2024
Development of compact transcriptional effectors using high-throughput measurements in diverse contextsJosh Tycko, Mike V Van, Aradhana, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2025
Nivolumab-AVD Versus Brentuximab Vedotin-AVD in Older Patients With Advanced-Stage Classic Hodgkin Lymphoma Enrolled on S1826Sarah C Rutherford, Hongli Li, Alex F Herrera, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 9, 2021
Phase I Trial of N-803, an IL15 Receptor Agonist, with Rituximab in Patients with Indolent Non-Hodgkin LymphomaJennifer A Foltz, Brian T Hess, Veronika Bachanova, et al.
American Journal of Hematology|January 2, 2023
Outcomes of patients with limited-stage plasmablastic lymphoma: A multi-institutional retrospective studyBrian T Hess, Anshu Giri, Yeonhee Park, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 29, 2020
Metabolic precision labeling enables selective probing of O-linked N-acetylgalactosamine glycosylationMarjoke F Debets, Omur Y Tastan, Simon P Wisnovsky, et al.
Pageof 47